Invitro evaluation of bovine lactoferrin potential as an anticancer agent

International Dairy Journal

Volumn 40, Issue , 2015, Pages 6-15

  Zhang, Yunlei ^a,c   Lima, Cristovao F ^b   Rodrigues, Ligia R ^a  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^c HUNAN NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-CANCER AGENTS; BOVINE LACTOFERRIN; IN-VITRO EVALUATION;

EID: 84908032173     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2014.08.016     Document Type: Article

References (44)

1. Adlerova L., Bartoskova A., Faldyna M. Lactoferrin: a review. Veterinarni Medicina 2008, 53:457-468.
2. Balcão V.M., Costa C.I., Matos C.M., Moutinho C.G., Amorim M., Pintado M.E., et al. Nanoencapsulation of bovine lactoferrin for food and biopharmaceutical applications. Food Hydrocolloids 2013, 32:425-432.
3. Bi B.Y., Liu J.L., Legrand D., Roche A.C., Capron M., Spik G., et al. Internalization of human lactoferrin by the Jurkat human lymphoblastic T-cell line. European Journal of Cell Biology 1996, 69:288-296.
4. Breton M., Mariller C., Benaïssa M., Caillaux K., Browaeys E., Masson M., et al. Expression of delta-lactoferrin induces cell cycle arrest. Biometals 2004, 17:325-329.
5. Damiens E., El Yazidi I., Mazurier J., Duthille I., Spik G., Boilly-Marer Y. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. Journal of Cellular Biochemistry 1999, 74:486-498.
6. De la Rosa G., Yang D., Tewary P., Varadhachary A., Oppenheim J.J. Lactoferrin acts as an alarmin to promote the recruitment and activation of APCs and antigen-specific immune responses. Journal of Immunology 2008, 180:6868-6876.
7. Dias T.A., Duarte C.L., Lima C.F., Proença M.F., Pereira-Wilson C. Superior anticancer activity of halogenated chalcones and flavonols over the natural flavonol quercetin. European Journal of Medicinal Chemistry 2013, 65:500-510.
8. Duarte D., Nicolau A., Teixeira J., Rodrigues L. The effect of bovine milk lactoferrin on human breast cancer cell lines. Journal of Dairy Science 2011, 94:66-76.
9. Eliassen L.T., Berge G., Leknessund A., Wikman M., Lindin I., Løkke C., et al. The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells invitro and inhibits xenograft growth invivo. International Journal of Cancer 2006, 119:493-500.
10. Elmore S. Apoptosis: a review of programmed cell death. Toxicologic Pathology 2007, 35:495-516.
11. Fischer R., Debbabi H., Dubarry M., Boyaka P., Tome D. Regulation of physiological and pathological Th1 and Th2 responses by lactoferrin. Biochemistry and Cell Biology 2006, 84:303-311.
12. Furlong S.J., Mader J.S., Hoskin D.W. Lactoferricin-induced apoptosis in estrogen-nonresponsive MDA-MB-435 breast cancer cells is enhanced by C6 ceramide or tamoxifen. Oncology Reports 2006, 15:1385-1390.
13. Furmanski P., Li Z., Fortuna M.B., Swamy C., Das M.R. Multiple molecular forms of human lactoferrin. Identification of a class of lactoferrins that possess ribonuclease activity and lack iron-binding capacity. Journal of Experimental Medicine 1989, 170:415-429.
14. Gottlieb E., Armour S., Harris M., Thompson C. Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis. Cell Death and Differentiation 2003, 10:709-717.
15. Ha N.-H., Nair V.S., Reddy D.N.S., Mudvari P., Ohshiro K., Ghanta K.S., et al. Lactoferrin-endothelin-1 axis contributes to the development and invasiveness of triple-negative breast cancer phenotypes. Cancer Research 2011, 71:7259-7269.
16. Hu K., Shi Y., Jiang W., Han J., Huang S., Jiang X. Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson's disease. International Journal of Pharmacology 2011, 415:273-283.
17. Jänicke R.U. MCF-7 breast carcinoma cells do not express caspase-3. Breast Cancer Research and Treatment 2009, 117:219-221.
18. Jenssen H., Hancock R.E. Antimicrobial properties of lactoferrin. Biochimie 2009, 91:19-29.
19. Kappeler S.R., Ackermann M., Farah Z., Puhan Z. Sequence analysis of camel (Camelus dromedarius) lactoferrin. International Dairy Journal 1999, 9:481-486.
20. Korhonen H., Pihlanto A. Bioactive peptides: production and functionality. International Dairy Journal 2006, 16:945-960.
21. Kuhara T., Iigo M., Itoh T., Ushida Y., Sekine K., Terada N., et al. Orally administered lactoferrin exerts an antimetastatic effect and enhances production of IL-18 in the intestinal epithelium. Nutrition and Cancer 2000, 38:192-199.
22. Kuhara T., Yamauchi K., Iwatsuki K. Bovine lactoferrin induces interleukin-11 production in a hepatitis mouse model and human intestinal myofibroblasts. European Journal of Nutrition 2012, 51:343-351.
23. Lee S.H., Park S.W., Pyo C.W., Yoo N.K., Kim J., Choi S.Y. Requirement of the JNK-associated Bcl-2 pathway for human lactoferrin-induced apoptosis in the Jurkat leukemia T cell line. Biochimie 2009, 91:102-108.
24. Liao Y., Du X., Lönnerdal B. miR-214 regulates lactoferrin expression and pro-apoptotic function in mammary epithelial cells. Journal of Nutrition 2010, 140:1552-1556.
25. Liao Y., Jiang R., Lonnerdal B. Biochemical and molecular impacts of lactoferrin on small intestinal growth and development during early life. Biochemistry and Cell Biology 2012, 90:476-484.
26. Lin T.Y., Chiou S.H., Chen M., Kuo C.D. Human lactoferrin exerts bi-directional actions on PC12 cell survival via ERK1/2 pathway. Biochemical and Biophysical Research Communications 2005, 337:330-336.
27. Lonnerdal B., Jiang R., Du X. Bovine lactoferrin can be taken up by the human intestinal lactoferrin receptor and exert bioactivities. Journal of Pediatric Gastroenterology and Nutrition 2011, 53:606-614.
28. Ly J., Grubb D., Lawen A. The mitochondrial membrane potential (δΨm) in apoptosis; an update. Apoptosis 2003, 8:115-128.
29. Mader J.S., Salsman J., Conrad D.M., Hoskin D.W. Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines. Molecular Cancer Therapeutics 2005, 4:612-624.
30. Meulmeester E., Jochemsen A.G. p53: a guide to apoptosis. Current Cancer Drug Targets 2008, 8:87-97.
31. 165-mediated angiogenesis in the rat. International Journal of Cancer 2001, 91:236-240.
32. Onishi J., Roy M.K., Juneja L.R., Watanabe Y., Tamai Y. Alactoferrin-derived peptide with cationic residues concentrated in a region of its helical structure induces necrotic cell death in a leukemic cell line (HL-60). Journal of Peptide Science 2008, 14:1032-1038.
33. Rodrigues L.R. Milk minor constituents, enzymes, hormones, growth factors, and organic acids. Milk and dairy products in human nutrition 2013, Vol. 11:220-245. Wiley-Blackwell, Somerset, NJ, USA.
34. Roy M., Kuwabara Y., Hara K., Watanabe Y., Tamai Y. Peptides from the N-terminal end of bovine lactoferrin induce apoptosis in human leukemic (HL-60) cells. Journal of Dairy Science 2002, 85:2065-2074.
35. Sakai T., Banno Y., Kato Y., Nozawa Y., Kawaguchi M. Pepsin-digested bovine lactoferrin induces apoptotic cell death with JNK/SAPK activation in oral cancer cells. Journal of Pharmacological Sciences 2005, 98:41-48.
36. Syed D.N., Khan N., Afaq F., Mukhtar H. Chemoprevention of prostate cancer through dietary agents: progress and promise. Cancer Epidemiology Biomarkers and Prevention 2007, 16:2193-2203.
37. Valster A., Tran N.L., Nakada M., Berens M.E., Chan A.Y., Symons M. Cell migration and invasion assays. Methods 2005, 37:208-215.
38. Wakabayashi H., Yamauchi K., Takase M. Lactoferrin research, technology and applications. International Dairy Journal 2006, 16:1241-1251.
39. Wang J., Li Q., Ou Y., Han Z., Li K., Wang P., et al. Inhibition of tumor growth by recombinant adenovirus containing human lactoferrin through inducing tumor cell apoptosis in mice bearing EMT6 breast cancer. Archives of Pharmacal Research 2011, 34:987-995.
40. Wang J., Li Q., Ou Y., Li K., Han Z., Wang P., et al. Recombination adenovirus-mediated human lactoferrin cDNA inhibits the growth of human MCF-7 breast cancer cells. Journal of Pharmacy and Pharmacology 2012, 64:457-463.
41. Xu X., Jiang H., Li H., Zhang T., Zhou Q., Liu N. Apoptosis of stomach cancer cell SGC-7901 and regulation of Akt signaling way induced by bovine lactoferrin. Journal of Dairy Science 2010, 93:2344-2350.
42. Xu H., Shan J., Jurukovski V., Yuan L., Li J., Tian K. TSP50 encodes a testis-specific protease and is negatively regulated by p53. Cancer Research 2007, 67:1239-1245.
43. Yamada Y., Sato R., Kobayashi S., Hankanga C., Inanami O., Kuwabara M., et al. The antiproliferative effect of bovine lactoferrin on canine mammary gland tumor cells. Journal of Veterinary Medical Science/Japanese Society of Veterinary Science 2008, 70:443.
44. Zhou Y., Zeng Z., Zhang W., Xiong W., Wu M., Tan Y., et al. Lactotransferrin: a candidate tumor suppressor-Deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway. International Journal of Cancer 2008, 123:2065-2072.